Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation

被引:0
|
作者
S Agrawal
S Koschmieder
N Bäumer
N G P Reddy
W E Berdel
C Müller-Tidow
H Serve
机构
[1] Hematology and Oncology,Department of Medicine
[2] University of Münster,undefined
[3] Medizinische Klinik II,undefined
[4] Johann Wolfgang Goethe Universität,undefined
来源
Leukemia | 2008年 / 22卷
关键词
acute myeloid leukemia; signal transduction; cell cycle regulation; pim kinases; Fms-like tyrosine kinase-3;
D O I
暂无
中图分类号
学科分类号
摘要
Pim2 is a serine/threonine kinase expressed at high levels in several malignancies including acute leukemia. Pim2 protein is induced by oncogenic Fms-like tyrosine kinase-3 (Flt3)-internal tandem duplications (ITD), but not by Flt3 wild-type receptor (Flt3-Wt) in response to Flt3 ligand (FL). Here we show that Pim2 can complement Flt3-Wt signaling and induce transformation similar to Flt3-ITD in myeloid cells. Our data demonstrate that Pim2 is necessary but not sufficient for Flt3-ITD-induced transformation of 32D cells and primary bone marrow cells as assessed by colony assays. Pim2-induced clonogenic growth of FL-treated 32D-Flt3-Wt cells. Proliferation of 32D-Flt3-Wt cells was significantly enhanced in FL-treated Pim2-overexpressing cells. This increase was associated with enhanced S-phase cell cycle progression. Pim2-overexpressing cells were resistant to apoptosis induced by growth factor deprivation or treatment with tyrosine kinase inhibitor (PKC412). The Flt3 point mutant D835Y, which is not able to support colony growth of myeloid cells, also induced clonogenic growth in the presence of Pim2. In conclusion, Pim2 is an important target of Flt3-ITD-induced transformation, and overexpression of Pim2 together with Flt3-Wt or D835Y receptor mimics Flt3-ITD-mediated transformation. Pim2 complements with Flt3-Wt signaling to induce proliferation by enhancing G1/S-phase progression of the cell cycle.
引用
收藏
页码:78 / 86
页数:8
相关论文
共 50 条
  • [31] Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia (vol 16, e0247093, 2021)
    Orgueira, Adrian Mosquera
    Raindo, Andres Peleteiro
    Lopez, Miguel Cid
    Rodriguez, Beatriz Antelo
    Arias, Jose Angel Diaz
    Ferro, Roi Ferreiro
    Vence, Natalia Alonso
    Lopez, Angeles Bendana
    Blanco, Aitor Abuin
    Perez, Laura Bao
    Valentin, Paula Melero
    Perez, Marta Sonia Gonzalez
    Cerchione, Claudio
    Martinelli, Giovanni
    Fernandez, Pau Montesinos
    Encinas, Manuel Mateo Perez
    Lopez, Jose Luis Bello
    PLOS ONE, 2022, 17 (09):
  • [32] Loss of flk-2/flt3 expression during commitment of multipotent mouse hematopoietic progenitor cells to the mast cell lineage
    Pharr, PN
    Hofbauer, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (07) : 620 - 628
  • [33] Loss of the Wild-Type Allele Contributes to Myeloid Expansion and Disease Aggressiveness in FLT3/ITD Knock-in Mice
    Li, Li
    Bailey, Emily
    Greenblatt, Sarah M.
    Huso, David
    Small, Donald
    BLOOD, 2011, 118 (21) : 395 - 395
  • [34] Effect of Small Interfering RNA Targeting Wild-type FLT3 in Acute Myeloid Leukaemia Cells In Vitro and In Vivo
    Wang, C-M
    Sheng, G-Y
    Lu, J.
    Xie, L.
    Bai, S-T
    Xu, X-J
    Liu, Y-F
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 1661 - 1674
  • [35] In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloi leukemia with wild-type FLT3 receptor
    Zhou, Jianbiao
    Khng, Jiaying
    Jasinghe, Viraj J.
    Bi, Chonglei
    Neo, Chiew Hoon Serene
    Pan, Mengfei
    Poon, Lai Fong
    Xie, Zhigang
    Yu, Hanry
    Yeoh, Allen Eng-Juh
    Lu, Yi
    Glaser, Keith B.
    Albert, Daniel H.
    Davidsen, Steven K.
    Chen, Chien-Shing
    LEUKEMIA RESEARCH, 2008, 32 (07) : 1091 - 1100
  • [36] Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
    Maiorova, Varvara
    Mollaev, Murad D.
    Vikhreva, Polina
    Chudakov, Dmitriy M.
    Kibardin, Alexey
    Maschan, Michael A.
    Larin, Sergey
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [37] Flt3 receptor expression rescues dendritic cell developmental potential in megakaryocyte/erythrocyte progenitor cells.
    Onai, N
    Onai, A
    Tussiwand, R
    Lanzavecchia, A
    Manz, MG
    BLOOD, 2004, 104 (11) : 595A - 595A
  • [38] The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial
    Mosquera Orgueira, Adrian
    Perez Encinas, Manuel
    Diaz Arias, Jose Angel
    Rodriguez Veiga, Rebeca
    Bergua Burgues, Juan Miguel
    Lorenzo Algarra, Jesus
    Botella, Carmen
    Perez Simon, Jose Antonio
    Bernal, Teresa
    Tormo, Mar
    Calbacho, Maria
    Salamero, Olga
    Serrano, Josefina
    Noriega, Victor
    Lopez Lopez, Juan Antonio
    Vives, Susana
    Colorado, Mercedes
    Lopez Lorenzo, Jose Luis
    Vidriales Vicente, Maria
    Garcia Boyero, Raimundo
    Olave Rubio, Maria Teresa
    Herrera Puente, Pilar
    Arce, Olga
    Barrios Garcia, Manuel
    Sayas Lloris, Maria Jose
    Polo, Marta
    Gomez Roncero, Maria Isabel
    Barragan, Eva
    Ayala, Rosa
    Chillon, Carmen
    Jose Calasanz, Maria
    Boluda, Blanca
    Peleteiro Raindo, Andres
    Amigo, Raquel
    Martinez Cuadron, David
    Labrador, Jorge
    Montesinos, Pau
    BLOOD, 2023, 142
  • [39] Administration of a wild-type p53 genetic vaccine with Flt3 ligand induces a tumor-specific type 1 T-cell response
    Parajuli, P
    Pisarev, V
    Laface, D
    Sublet, J
    Talmadge, JE
    CANCER GENE THERAPY, 1999, 6 (06) : S26 - S27
  • [40] The role of flt3 and EPO receptor expressions on CD34+hematopoietic stem cell differentiation and proliferation
    Xu, J
    Hao, HN
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 121 - 121